Screener
Amneal Pharmaceuticals, Inc. AMRX International — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Oral liquid | 10,371 | 17,879 | 22,463 | 41,427 |
| Other dosage forms (1) | 81,594 | 68,185 | 128,206 | 124,607 |
| Subtotal dosage forms | 482,300 | 431,524 | 900,218 | 844,998 |
| International | 7,613 | 1,901 | 12,932 | 3,135 |
| Total Affordable Medicines net revenue | 489,913 | 433,425 | 913,150 | 848,133 |
| Specialty | ||||
| Central nervous system | 95,344 | 83,425 | 178,727 | 151,035 |
| Hormonal / allergy | 42,099 | 35,418 | 78,031 | 69,617 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s international — net revenue?
- Amneal Pharmaceuticals, Inc. (AMRX) reported international — net revenue of $7.61M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s international — net revenue changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s international — net revenue increased by 300.5% year-over-year, from $1.9M to $7.61M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s international — net revenue?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s international — net revenue has grown at a 102.1% compound annual growth rate (CAGR), from $1.47M to $12.13M.
- What does international — net revenue mean?
- This metric represents the total gross sales generated from products sold outside of the company's primary domestic market, net of returns, allowances, and discounts. It serves as a key indicator of the company's geographic diversification and the success of its global commercial expansion strategy. Monitoring this revenue stream helps investors assess the company's ability to capture market share in international territories and mitigate reliance on domestic economic conditions.
Ask your AI about Amneal Pharmaceuticals, Inc.'s international — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude